NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 218 filers reported holding NEVRO CORP in Q3 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,717 | -92.0% | 1,338 | -89.4% | 0.00% | – |
| Q2 2023 | $322,046 | +325.6% | 12,669 | +505.3% | 0.00% | – |
| Q1 2023 | $75,662 | -86.5% | 2,093 | -85.2% | 0.00% | – |
| Q4 2022 | $558,994 | +323.5% | 14,116 | +401.6% | 0.00% | – |
| Q3 2022 | $132,000 | -38.3% | 2,814 | -42.2% | 0.00% | – |
| Q2 2022 | $214,000 | +25.9% | 4,872 | +107.9% | 0.00% | – |
| Q1 2022 | $170,000 | -78.3% | 2,343 | -75.7% | 0.00% | – |
| Q4 2021 | $783,000 | +47.7% | 9,658 | +112.3% | 0.00% | – |
| Q3 2021 | $530,000 | -6.5% | 4,550 | +33.0% | 0.00% | – |
| Q2 2021 | $567,000 | -57.0% | 3,421 | -63.8% | 0.00% | -100.0% |
| Q1 2021 | $1,320,000 | -70.1% | 9,457 | -63.0% | 0.00% | -66.7% |
| Q4 2020 | $4,421,000 | +42.1% | 25,538 | +14.4% | 0.00% | +50.0% |
| Q3 2020 | $3,111,000 | -2.8% | 22,332 | -16.7% | 0.00% | 0.0% |
| Q2 2020 | $3,201,000 | +6.6% | 26,795 | -10.7% | 0.00% | -33.3% |
| Q1 2020 | $3,002,000 | +31.8% | 30,021 | +55.0% | 0.00% | +50.0% |
| Q4 2019 | $2,277,000 | +35.7% | 19,371 | -0.8% | 0.00% | +100.0% |
| Q3 2019 | $1,678,000 | -65.6% | 19,522 | -74.1% | 0.00% | -75.0% |
| Q2 2019 | $4,879,000 | -28.7% | 75,259 | -31.3% | 0.00% | -42.9% |
| Q1 2019 | $6,845,000 | +974.6% | 109,509 | +567.9% | 0.01% | – |
| Q4 2018 | $637,000 | +31.3% | 16,397 | +92.6% | 0.00% | – |
| Q3 2018 | $485,000 | +357.5% | 8,512 | +541.4% | 0.00% | – |
| Q2 2018 | $106,000 | +120.8% | 1,327 | +138.7% | 0.00% | – |
| Q1 2018 | $48,000 | +17.1% | 556 | -7.0% | 0.00% | – |
| Q4 2017 | $41,000 | -82.1% | 598 | -76.3% | 0.00% | – |
| Q3 2017 | $229,000 | +593.9% | 2,519 | +464.8% | 0.00% | – |
| Q2 2017 | $33,000 | +3.1% | 446 | +32.3% | 0.00% | – |
| Q1 2017 | $32,000 | -87.9% | 337 | -90.7% | 0.00% | – |
| Q4 2016 | $264,000 | +28.8% | 3,631 | +85.3% | 0.00% | – |
| Q3 2016 | $205,000 | -32.6% | 1,959 | -52.3% | 0.00% | – |
| Q2 2016 | $304,000 | -58.4% | 4,106 | -68.4% | 0.00% | -100.0% |
| Q1 2016 | $731,000 | +4773.3% | 13,009 | +5605.7% | 0.00% | – |
| Q4 2015 | $15,000 | -95.7% | 228 | -97.0% | 0.00% | – |
| Q3 2015 | $348,000 | +3063.6% | 7,503 | +3708.6% | 0.00% | – |
| Q2 2015 | $11,000 | -50.0% | 197 | -58.1% | 0.00% | – |
| Q1 2015 | $22,000 | -58.5% | 470 | -65.9% | 0.00% | – |
| Q4 2014 | $53,000 | – | 1,380 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |